Trial
NCT03879629
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
National Cancer Institute (NCI); Miami Heart Research Institute
Condition
Breast Cancer
Intervention
Carvedilol
Why stopped
slow accrual; insufficient funding to continue to accrue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-15